5-aminomethyl-2-N,N-dimethylfurfurylamine | 158688-07-4

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: 5-aminomethyl-2-N,N-dimethylfurfurylamine
• 英文别名: 1-(5-(aminomethyl)furan-2-yl)-N,N-dimethylmethanamine；[5-[(Dimethylamino)methyl]furan-2-yl]methanamine
• CAS: 158688-07-4
• 化学式: C₈H₁₄N₂O
• 分子量: 154.212
• InChiKey: GCKKYPRRZHWOET-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.2
• 重原子数：
  11
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  42.4
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  5-aminomethyl-2-N,N-dimethylfurfurylamine 在 盐酸 、 PS-carbodiimide 、 1-羟基苯并三唑 作用下， 以 二氯甲烷 、 二甲基亚砜 、 乙腈 为溶剂， 反应 0.42h， 生成 DHK97
  参考文献：
  名称：

  WO2008/124703

  摘要：

  公开号：
• 作为产物：
  描述：

  2-(furan-2-ylmethyl)isoindoline-1,3-dione 在 一水合肼 、 溶剂黄146 作用下， 以 乙醇 为溶剂， 反应 8.0h， 生成 5-aminomethyl-2-N,N-dimethylfurfurylamine
  参考文献：
  名称：

  Cholinergic agents structurally related to furtrethonium. 1

  摘要：

  A series of 5-substituted-2-(dimethylaminomethyl)-furyl derivatives 4 was prepared, with the aim of discovering novel antimuscarinic agents which are selective for smooth muscle as opposed to cardiac tissue. Both non-quaternary and quaternary ammonium compounds were synthesised. The agonist starting point, furtrethonium 3, was gradually transformed into antagonist by introduction of lipophilic and bulky groups in position 5 of this molecule. In particular, the introduction of alpha-hydroxy-alpha-cyclohexylbenzyl moiety (compound 9b), a lipophilic group characteristic of antimuscarinic agents, caused an appreciable increase of the antagonist's potency, and the lengthening of the distance between this lipophilic group and the furan ring, obtained by introduction of an ester, ether or amide group, led to some selectivity towards smooth muscle (compounds 19, 21, 25). Interestingly, compound 19, with an ester moiety as a spacer group, proved to be at least 20 times more potent in rat ileum (pK(B) = 7.3) and rat bladder (pK(B) = 7.2) than guinea-pig atria (pK(B) = 5.9).

  DOI：

  10.1016/0223-5234(94)90213-5

文献信息

• Pyrazole compounds and pharmaceutical compositions comprising the compound
  申请人：Ohi Norihito

  公开号：US20050208582A1

  公开（公告）日：2005-09-22

  The present invention provides a novel compound having an excellent JNK inhibitory effect. That is, it provides a compound represented by the following formula, a salt thereof or a hydrate of them. Wherein R 1 designates —(CO h —(NR a ) j —(CR b ═CR c ) k —Ar (wherein R a , R b and R c each independently designate a hydrogen atom, a halogen atom, hydroxyl group, an optionally substituted C 1-6 alkyl group or the like; Cy designates a 5- or 6-membered heteroaryl; and V each independently designate the formula -L-X—Y (wherein L designates a single bond, an optionally substituted C 1-6 alkylene group or the like; X designates a single bond or the formula -A- (wherein A designates NR 2 , O, CO, S, SO or SO 2 ) and so on; and Y designates a hydrogen atom, a halogen atom, nitro group or the like).

  本发明提供了一种具有优异的JNK抑制作用的新型化合物。即，提供了下式所示的化合物，其盐或水合物。其中，R1表示—(COh—(NRa)j—(CRb═CRc)k—Ar（其中Ra，Rb和Rc各自独立地表示氢原子，卤素原子，羟基，选自C1-6烷基等的可选取代基团；Cy表示5-或6-成员杂环芳基；V各自独立地表示公式-L-X—Y（其中L表示单键，选自C1-6烷基等的可选取代基团；X表示单键或公式-A-（其中A表示NR2，O，CO，S，SO或SO2）等；Y表示氢原子，卤素原子，硝基或类似物）。
• DEVELOPMENT OF MOLECULAR IMAGING PROBES FOR CARBONIC ANHYDRASE-IX USING CLICK CHEMISTRY
  申请人：Kolb Hartmuth C.

  公开号：US20090123372A1

  公开（公告）日：2009-05-14

  The present application discloses methods for identifying inhibitors with high binding-affinity for the carbonic anhydrase-IX (CA-IX) enzyme using click chemistry and uses the candidates thereof as positron emission tomography (PET) imaging agents.

  本申请公开了使用点击化学方法鉴定高亲和力的碳酸酐酶IX（CA-IX）酶抑制剂的方法，并将其候选物作为正电子发射断层扫描（PET）成像剂。
• PYRAZOLE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE COMPOUND
  申请人：Ohi Norihito

  公开号：US20090054397A1

  公开（公告）日：2009-02-26

  The present invention provides a novel compound having an excellent JNK inhibitory effect. That is, it provides a compound represented by the following formula, a salt thereof or a hydrate of them. Wherein R 1 designates —(CO) h —(NR a ) j —(CR b ═CR c ) k —Ar (wherein R a , R b and R c each independently designate a hydrogen atom, a halogen atom, hydroxyl group, an optionally substituted C 1-6 alkyl group or the like; Cy designates a 5- or 6-membered heteroaryl; and V each independently designate the formula -L-X—Y (wherein L designates a single bond, an optionally substituted C 1-6 alkylene group or the like; X designates a single bond or the formula -A- (wherein A designates NR 2 , O, CO, S, SO or SO 2 ) and so on; and Y designates a hydrogen atom, a halogen atom, nitro group or the like).

  本发明提供了一种具有出色JNK抑制作用的新化合物。即提供了由以下公式表示的化合物，其盐或水合物。其中，R1代表—(CO)h—(NRa)j—(CRb═CRc)k—Ar（其中，Ra，Rb和Rc各自独立地代表氢原子，卤素原子，羟基，可选取代的C1-6烷基或类似物；Cy代表5或6成员的杂环芳基；V各自独立地代表公式-L-X-Y（其中，L代表单键，可选取代的C1-6亚烷基或类似物；X代表单键或公式-A-（其中，A代表NR2，O，CO，S，SO或SO2）等；Y代表氢原子，卤素原子，硝基或类似物）。
• Heterocyclic Derivatives
  申请人：Gillen Kevin James

  公开号：US20080255086A1

  公开（公告）日：2008-10-16

  The present invention relates to a heterocyclic derivative according to formula I wherein the variables are defined as in the specification, or to a pharmaceutically acceptable salt or solvate thereof. The present invention also relates to a pharmaceutical composition comprising said heterocyclic derivatives and to their use in therapy, for instance in the treatment or prevention of psychiatric diseases where an enhancement of synaptic responses mediated by AMPA receptors is required, including schizophrenia, depression and Alzheimer's disease.

  本发明涉及式I的杂环衍生物，其中变量如规范中所定义，或其药学上可接受的盐或溶剂。本发明还涉及包含上述杂环衍生物的制药组合物，以及它们在治疗中的使用，例如在需要增强由AMPA受体介导的突触反应的精神疾病的治疗或预防中，包括精神分裂症、抑郁症和阿尔茨海默病。
• Development of Molecular Imaging Probes for Carbonic Anhydrase-IX Using Click Chemistry
  申请人：Kolb Hartmuth C.

  公开号：US20100317842A1

  公开（公告）日：2010-12-16

  The present application discloses methods for identifying inhibitors with high binding-affinity for the carbonic anhydrase-IX (CA-IX) enzyme using click chemistry and uses the candidates thereof as positron emission tomography (PET) imaging agents.

  本申请公开了一种使用点击化学方法鉴定高亲和力碳酸酐酶IX（CA-IX）酶抑制剂的方法，并将其候选物作为正电子发射断层扫描（PET）成像剂。